418
Views
0
CrossRef citations to date
0
Altmetric
Letters to the editor: Original Scientific Contribution

Tirzepatide-associated starvation ketoacidosis

ORCID Icon, , ORCID Icon, ORCID Icon &
Pages 1064-1065 | Received 18 Aug 2023, Accepted 25 Oct 2023, Published online: 08 Nov 2023

References

  • Kennelly PJ, Botham KM, McGuinness OP, et al., editors. Harper’s illustrated biochemistry. Thirty-second edition. New York: McGraw Hill; 2023.
  • Slade S, Ashurst J. Diet-induced ketoacidosis in a non-diabetic: a case report. Clin Pract Cases Emerg Med. 2020;4(2):259–262. doi: 10.5811/cpcem.2020.2.44736.
  • Krauss Z, Hintz A, Fisk R. Tirzepatide: clinical review of the "twincretin" injectable. Am J Health Syst Pharm. 2023;80(14):879–888. doi:10.1093/ajhp/zxad080.
  • Bradley CL, McMillin SM, Hwang AY, et al. Tirzepatide, the newest medication for type 2 diabetes: a review of the literature and implications for clinical practice. Ann Pharmacother. 2023;57(7):822–836. doi:10.1177/10600280221134127.
  • Naranjo CA, Busto U, Sellers EM, et al. Evidencio. Anion Gap. Evidencio. https://www.evidencio.com/models/show/661. Accessed September 15, 2023.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.